Thomas Talbot
Impact in
- Dermatology top 1%
- Dermatology and Skin Diseases
- Hepatology top 2%
- Liver Diseases and Immunity
Papers in
- Co-authors
- Nora V. Bergasa (6 shared papers)Stephen E. Epstein (2 shared papers)David W. Alling (5 shared papers)E. Anthony Jones (5 shared papers)Joseph M. Schmitt (4 shared papers)Elijah C. Walker (3 shared papers)Maria L. Turner (3 shared papers)Cihan Yurdaydın (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Microscopy and Microanalysis (2 papers)The Journal of the Acoustical Society of America (2 papers)Annals of Oncology (2 papers)The American Journal of Cardiology (2 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Thomas Talbot
44 papers receiving 1.8k citations
Thomas Talbot's Hit Papers
Peers
Comparison fields: 5 of 116
- Dermatology 376
- Hepatology 322
- Structural Biology 51
- Rehabilitation 119
- Pharmacology 142
Countries citing papers authored by Thomas Talbot
This map shows the geographic impact of Thomas Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Talbot more than expected).
Fields of papers citing papers by Thomas Talbot
This network shows the impact of papers produced by Thomas Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Talbot. The network helps show where Thomas Talbot may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Talbot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 296 | |
| 2 | 1992 | 228 | |
| 3 | First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 Hit paper breakdown → | 2022 | 166 |
| 4 | 1981 | 147 | |
| 5 | 1998 | 145 | |
| 6 | 1999 | 118 | |
| 7 | 1991 | 81 | |
| 8 | 1991 | 76 | |
| 9 | 1985 | 74 | |
| 10 | 2004 | 69 | |
| 11 | 1988 | 53 | |
| 12 | 1993 | 45 | |
| 13 | 1983 | 43 | |
| 14 | 1954 | 39 | |
| 15 | 2021 | 31 | |
| 16 | 1986 | 30 | |
| 17 | 2017 | 29 | |
| 18 | 2022 | 27 | |
| 19 | 1991 | 25 | |
| 20 | 1981 | 23 |
About Thomas Talbot
Thomas Talbot is a scholar working on Oncology, Surgery, Dermatology, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 45 papers that have together received 1.9k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Wound Healing and Treatments (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Reconstructive Surgery and Microvascular Techniques (3 papers), Cardiac Imaging and Diagnostics (3 papers) and Cardiac Valve Diseases and Treatments (3 papers). The work is most often cited by research in Dermatology (376 citations), Hepatology (322 citations), Structural Biology (51 citations), Rehabilitation (119 citations) and Pharmacology (142 citations). Thomas Talbot has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Nora V. Bergasa, Stephen E. Epstein, David W. Alling, E. Anthony Jones, Joseph M. Schmitt, Elijah C. Walker, Maria L. Turner, Cihan Yurdaydın, M.G. Swain and GARY D. SALOMON. Their work appears in journals such as Journal of Clinical Oncology, Microscopy and Microanalysis, The Journal of the Acoustical Society of America, Annals of Oncology and The American Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.